Mechanistically, we find that R-RAS2 protein is physically and functionally associated to the BCR, being important for the activation of the PI3K-Akt-mTOR and other BCR-driven pathways, thus linking R-RAS2 with a previously known player in CLL cell survival and proliferation. Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.